Lilly’s Ebglyss® for moderate-to-severe atopic dermatitis (eczema) listed on Quebec’s public drug formulary Financial Times Source link
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval Everyday Health Source link